

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.62874413 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.33416384 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.22537132 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17609811 |
| 5 | negative thymic T cell selection (GO:0045060) | 4.01072731 |
| 6 | negative regulation of cell killing (GO:0031342) | 3.82114168 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.82114168 |
| 8 | negative T cell selection (GO:0043383) | 3.76426023 |
| 9 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.62316817 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.44624303 |
| 11 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.39439685 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.39287944 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 3.38093910 |
| 14 | leukocyte aggregation (GO:0070486) | 3.35398566 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.31877833 |
| 16 | response to interleukin-15 (GO:0070672) | 3.30217235 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.28592067 |
| 18 | positive thymic T cell selection (GO:0045059) | 3.26713078 |
| 19 | detection of bacterium (GO:0016045) | 3.26121734 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.22907599 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19654577 |
| 22 | positive regulation of granulocyte differentiation (GO:0030854) | 3.13132358 |
| 23 | T cell migration (GO:0072678) | 3.09812607 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 3.09121741 |
| 25 | detection of other organism (GO:0098543) | 3.08212528 |
| 26 | thymic T cell selection (GO:0045061) | 3.07047853 |
| 27 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.03756647 |
| 28 | mannose metabolic process (GO:0006013) | 2.98537187 |
| 29 | NIK/NF-kappaB signaling (GO:0038061) | 2.98427212 |
| 30 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.98399292 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 2.97726370 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 2.96708794 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 2.96708794 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.96708794 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.96708794 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.96708794 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 2.96708794 |
| 38 | base-excision repair, AP site formation (GO:0006285) | 2.96022493 |
| 39 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.94316016 |
| 40 | COPI coating of Golgi vesicle (GO:0048205) | 2.94282589 |
| 41 | Golgi transport vesicle coating (GO:0048200) | 2.94282589 |
| 42 | immunoglobulin mediated immune response (GO:0016064) | 2.92107570 |
| 43 | negative regulation of phagocytosis (GO:0050765) | 2.91475365 |
| 44 | negative regulation of fibrinolysis (GO:0051918) | 2.89199365 |
| 45 | response to type I interferon (GO:0034340) | 2.80961226 |
| 46 | cellular response to type I interferon (GO:0071357) | 2.79795284 |
| 47 | type I interferon signaling pathway (GO:0060337) | 2.79795284 |
| 48 | regulation of B cell differentiation (GO:0045577) | 2.77955842 |
| 49 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.74978703 |
| 50 | response to muramyl dipeptide (GO:0032495) | 2.74412637 |
| 51 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.74279500 |
| 52 | T cell selection (GO:0045058) | 2.73848550 |
| 53 | pinocytosis (GO:0006907) | 2.73007109 |
| 54 | response to peptidoglycan (GO:0032494) | 2.72387783 |
| 55 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.68865872 |
| 56 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.66324232 |
| 57 | regulation of granulocyte differentiation (GO:0030852) | 2.64981196 |
| 58 | modulation by virus of host process (GO:0019054) | 2.64877881 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 2.63055987 |
| 60 | cellular extravasation (GO:0045123) | 2.62258992 |
| 61 | negative regulation of innate immune response (GO:0045824) | 2.61394435 |
| 62 | cellular response to interleukin-4 (GO:0071353) | 2.61170736 |
| 63 | complement activation, alternative pathway (GO:0006957) | 2.58402277 |
| 64 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.55732947 |
| 65 | response to interferon-beta (GO:0035456) | 2.55547456 |
| 66 | actin filament polymerization (GO:0030041) | 2.52069096 |
| 67 | detection of external biotic stimulus (GO:0098581) | 2.51135859 |
| 68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.48217927 |
| 69 | myeloid dendritic cell differentiation (GO:0043011) | 2.47484938 |
| 70 | GDP-mannose metabolic process (GO:0019673) | 2.46880131 |
| 71 | neutrophil activation (GO:0042119) | 2.46613512 |
| 72 | regulation of T cell tolerance induction (GO:0002664) | 2.46396115 |
| 73 | B cell mediated immunity (GO:0019724) | 2.46116853 |
| 74 | myeloid dendritic cell activation (GO:0001773) | 2.43088586 |
| 75 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.41868800 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.41868800 |
| 77 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.39945958 |
| 78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37589618 |
| 79 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.35567172 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 2.34323150 |
| 81 | regulation of fibrinolysis (GO:0051917) | 2.33614945 |
| 82 | regulation of mast cell degranulation (GO:0043304) | 2.33296805 |
| 83 | germinal center formation (GO:0002467) | 2.32795632 |
| 84 | L-phenylalanine catabolic process (GO:0006559) | 2.31468076 |
| 85 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.31468076 |
| 86 | regulation of RIG-I signaling pathway (GO:0039535) | 2.30324894 |
| 87 | regulation of cholesterol esterification (GO:0010872) | 2.29169456 |
| 88 | regulation of monocyte differentiation (GO:0045655) | 2.28385671 |
| 89 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.28144868 |
| 90 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.28106640 |
| 91 | defense response to protozoan (GO:0042832) | 2.27755065 |
| 92 | cellular response to interferon-beta (GO:0035458) | 2.27185362 |
| 93 | L-phenylalanine metabolic process (GO:0006558) | 2.27083634 |
| 94 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.27083634 |
| 95 | granulocyte activation (GO:0036230) | 2.26634230 |
| 96 | regulation of necroptotic process (GO:0060544) | 2.25966330 |
| 97 | glyoxylate metabolic process (GO:0046487) | 2.25712677 |
| 98 | positive T cell selection (GO:0043368) | 2.25316209 |
| 99 | response to interleukin-4 (GO:0070670) | 2.25211907 |
| 100 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.24059954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 2.93738735 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.73227136 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.57894826 |
| 4 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16317334 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13571702 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12212260 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.05788031 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.01272708 |
| 9 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.94564001 |
| 10 | MAF_26560356_Chip-Seq_TH1_Human | 1.93115536 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.90371112 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89577534 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.88175433 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87596950 |
| 15 | UTX_26944678_Chip-Seq_JUKART_Human | 1.87105431 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85660961 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85166546 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.83622404 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80780103 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80350779 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.75696134 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.75580597 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 1.75393248 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.74256375 |
| 25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.73389924 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.73126656 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.73059275 |
| 28 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.67834459 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.67811805 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66355692 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.66116401 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65728647 |
| 33 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64024312 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.60119414 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59025019 |
| 36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.57991084 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57332538 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.55152136 |
| 39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54181863 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53902180 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53600661 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53136707 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52353654 |
| 44 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.49038062 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48336470 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.46316857 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45354248 |
| 48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44485718 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41992759 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41834017 |
| 51 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.41664062 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41613146 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40046749 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.39988556 |
| 55 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.37223447 |
| 56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35477998 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35082437 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34965795 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34959333 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34564021 |
| 61 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34509153 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33712746 |
| 63 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32831848 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.32333727 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31838595 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31063937 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29370808 |
| 68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29127923 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.27489239 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.25437593 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25011456 |
| 72 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23449245 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22368175 |
| 74 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22142996 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21931468 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21561552 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20536506 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20444115 |
| 79 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19641401 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19241122 |
| 81 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18929231 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17884668 |
| 83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14174050 |
| 84 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13746046 |
| 85 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12987365 |
| 86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12845346 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12786373 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12305085 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10684777 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09454640 |
| 91 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09126647 |
| 92 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08071986 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07750143 |
| 94 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07598143 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07355364 |
| 96 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06733599 |
| 97 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.06633076 |
| 98 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05104464 |
| 99 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.03505744 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02475894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.76206529 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.23411861 |
| 3 | MP0008260_abnormal_autophagy | 3.02513116 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.83279166 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.61547571 |
| 6 | MP0000685_abnormal_immune_system | 2.50706989 |
| 7 | MP0005671_abnormal_response_to | 2.42046338 |
| 8 | MP0005360_urolithiasis | 2.41516955 |
| 9 | MP0001800_abnormal_humoral_immune | 2.39265873 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.35737179 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.34716679 |
| 12 | MP0005025_abnormal_response_to | 2.29131169 |
| 13 | MP0002419_abnormal_innate_immunity | 2.28962172 |
| 14 | MP0001853_heart_inflammation | 2.22984439 |
| 15 | MP0003646_muscle_fatigue | 2.15748956 |
| 16 | MP0002723_abnormal_immune_serum | 2.09242459 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.04766154 |
| 18 | MP0003724_increased_susceptibility_to | 2.04597910 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.03447382 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.03182042 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.01215580 |
| 22 | MP0005387_immune_system_phenotype | 2.00797762 |
| 23 | MP0001790_abnormal_immune_system | 2.00797762 |
| 24 | MP0005451_abnormal_body_composition | 2.00394308 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.99553990 |
| 26 | MP0001819_abnormal_immune_cell | 1.97928645 |
| 27 | MP0009785_altered_susceptibility_to | 1.89685407 |
| 28 | MP0002398_abnormal_bone_marrow | 1.86237385 |
| 29 | MP0003303_peritoneal_inflammation | 1.83208158 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.75887615 |
| 31 | MP0009278_abnormal_bone_marrow | 1.75664520 |
| 32 | MP0004185_abnormal_adipocyte_glucose | 1.72782914 |
| 33 | MP0000716_abnormal_immune_system | 1.71600309 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.67892084 |
| 35 | MP0002722_abnormal_immune_system | 1.67438245 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.66959638 |
| 37 | MP0002405_respiratory_system_inflammati | 1.61383478 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.61223221 |
| 39 | MP0000858_altered_metastatic_potential | 1.58188123 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.57877598 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.56087833 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.54514534 |
| 43 | MP0009840_abnormal_foam_cell | 1.52636982 |
| 44 | MP0002429_abnormal_blood_cell | 1.51849769 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.49769243 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.43762115 |
| 47 | MP0005365_abnormal_bile_salt | 1.39947852 |
| 48 | MP0004947_skin_inflammation | 1.39926185 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.38196432 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.38196432 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.37499280 |
| 52 | MP0008469_abnormal_protein_level | 1.35153507 |
| 53 | MP0002132_abnormal_respiratory_system | 1.29850895 |
| 54 | MP0004381_abnormal_hair_follicle | 1.18843150 |
| 55 | MP0000490_abnormal_crypts_of | 1.17398857 |
| 56 | MP0002933_joint_inflammation | 1.16285766 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.15555405 |
| 58 | MP0006082_CNS_inflammation | 1.10714334 |
| 59 | MP0000609_abnormal_liver_physiology | 1.09424500 |
| 60 | MP0009764_decreased_sensitivity_to | 1.08208369 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.07445927 |
| 62 | MP0003111_abnormal_nucleus_morphology | 1.06501136 |
| 63 | MP0009763_increased_sensitivity_to | 1.03460665 |
| 64 | MP0003866_abnormal_defecation | 1.01875914 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.00135108 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 0.99840268 |
| 67 | MP0001849_ear_inflammation | 0.98205295 |
| 68 | MP0005076_abnormal_cell_differentiation | 0.98040725 |
| 69 | MP0001764_abnormal_homeostasis | 0.97247947 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.97083556 |
| 71 | MP0001666_abnormal_nutrient_absorption | 0.95517318 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 0.95155721 |
| 73 | MP0009384_cardiac_valve_regurgitation | 0.94195082 |
| 74 | MP0002019_abnormal_tumor_incidence | 0.93951030 |
| 75 | MP0001873_stomach_inflammation | 0.93518599 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.88527147 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 0.84981485 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.83400332 |
| 79 | MP0009115_abnormal_fat_cell | 0.82591585 |
| 80 | MP0005670_abnormal_white_adipose | 0.82014745 |
| 81 | MP0002006_tumorigenesis | 0.81896424 |
| 82 | MP0003693_abnormal_embryo_hatching | 0.81452582 |
| 83 | MP0000343_altered_response_to | 0.80505618 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 0.78860693 |
| 85 | MP0002009_preneoplasia | 0.78243985 |
| 86 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77945634 |
| 87 | MP0003136_yellow_coat_color | 0.77778559 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.77426744 |
| 89 | MP0000604_amyloidosis | 0.76311478 |
| 90 | MP0005408_hypopigmentation | 0.76252301 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.76106708 |
| 92 | MP0001270_distended_abdomen | 0.75563560 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 0.74262148 |
| 94 | MP0000598_abnormal_liver_morphology | 0.73632039 |
| 95 | MP0005390_skeleton_phenotype | 0.73217936 |
| 96 | MP0002837_dystrophic_cardiac_calcinosis | 0.71925914 |
| 97 | MP0005023_abnormal_wound_healing | 0.71084114 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.70350287 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.70287881 |
| 100 | MP0001851_eye_inflammation | 0.70245980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cutaneous melanoma (HP:0012056) | 5.58977131 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.46683434 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.70441304 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 3.56382533 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.51309282 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.35145060 |
| 7 | Myositis (HP:0100614) | 3.29581875 |
| 8 | Colitis (HP:0002583) | 3.21790799 |
| 9 | Agammaglobulinemia (HP:0004432) | 3.15725521 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.02453460 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.01858887 |
| 12 | Panhypogammaglobulinemia (HP:0003139) | 2.92752443 |
| 13 | Pustule (HP:0200039) | 2.84879555 |
| 14 | Dysostosis multiplex (HP:0000943) | 2.84268712 |
| 15 | Abnormality of macrophages (HP:0004311) | 2.81283206 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.80757720 |
| 17 | Gastrointestinal inflammation (HP:0004386) | 2.78016235 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 2.74744787 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.74054521 |
| 20 | Increased IgM level (HP:0003496) | 2.72760724 |
| 21 | Hemorrhage of the eye (HP:0011885) | 2.71815069 |
| 22 | Recurrent viral infections (HP:0004429) | 2.71006195 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.70976382 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.70976382 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.70976382 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.67597076 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 2.67597076 |
| 28 | Purpura (HP:0000979) | 2.67487537 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.67417791 |
| 30 | Mucopolysacchariduria (HP:0008155) | 2.67417791 |
| 31 | Recurrent skin infections (HP:0001581) | 2.62800068 |
| 32 | Increased IgE level (HP:0003212) | 2.61661707 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 2.61223542 |
| 34 | Inflammation of the large intestine (HP:0002037) | 2.60408140 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.59679150 |
| 36 | Obstructive lung disease (HP:0006536) | 2.59679150 |
| 37 | Meningitis (HP:0001287) | 2.57396222 |
| 38 | Complement deficiency (HP:0004431) | 2.55473324 |
| 39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.53674603 |
| 40 | Orchitis (HP:0100796) | 2.51424399 |
| 41 | Abnormality of complement system (HP:0005339) | 2.51198203 |
| 42 | Stomatitis (HP:0010280) | 2.48848127 |
| 43 | Seborrheic dermatitis (HP:0001051) | 2.46681723 |
| 44 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.45920658 |
| 45 | Microvesicular hepatic steatosis (HP:0001414) | 2.39151337 |
| 46 | Epistaxis (HP:0000421) | 2.38402463 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.37370683 |
| 48 | Joint hemorrhage (HP:0005261) | 2.36970071 |
| 49 | Vasculitis (HP:0002633) | 2.35301648 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.33023000 |
| 51 | Cellulitis (HP:0100658) | 2.32549683 |
| 52 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.32253366 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.31701692 |
| 54 | Ragged-red muscle fibers (HP:0003200) | 2.29765565 |
| 55 | Abnormality of T cells (HP:0002843) | 2.29738540 |
| 56 | Gingival bleeding (HP:0000225) | 2.29576711 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.28218603 |
| 58 | IgG deficiency (HP:0004315) | 2.27607932 |
| 59 | Prolonged partial thromboplastin time (HP:0003645) | 2.24541431 |
| 60 | Gingivitis (HP:0000230) | 2.21891026 |
| 61 | Lymphopenia (HP:0001888) | 2.21591804 |
| 62 | Encephalitis (HP:0002383) | 2.19189580 |
| 63 | Vertebral compression fractures (HP:0002953) | 2.18317381 |
| 64 | IgM deficiency (HP:0002850) | 2.18218940 |
| 65 | Increased serum ferritin (HP:0003281) | 2.17689147 |
| 66 | Granulocytopenia (HP:0001913) | 2.13428756 |
| 67 | Petechiae (HP:0000967) | 2.12854582 |
| 68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12059369 |
| 69 | Glomerulonephritis (HP:0000099) | 2.10995370 |
| 70 | Acute hepatic failure (HP:0006554) | 2.10485469 |
| 71 | Hypertensive crisis (HP:0100735) | 2.08420397 |
| 72 | Xanthomatosis (HP:0000991) | 2.07207509 |
| 73 | Optic neuritis (HP:0100653) | 2.05762010 |
| 74 | Retrobulbar optic neuritis (HP:0100654) | 2.05762010 |
| 75 | T lymphocytopenia (HP:0005403) | 2.04014100 |
| 76 | Viral hepatitis (HP:0006562) | 2.02734038 |
| 77 | Cervical subluxation (HP:0003308) | 2.02586127 |
| 78 | Small epiphyses (HP:0010585) | 2.02047835 |
| 79 | Gastrointestinal stroma tumor (HP:0100723) | 2.00756622 |
| 80 | Abnormality of T cell number (HP:0011839) | 1.94764292 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 1.93869943 |
| 82 | Biconcave vertebral bodies (HP:0004586) | 1.91263779 |
| 83 | Hyperglycinemia (HP:0002154) | 1.91176690 |
| 84 | Increased cerebral lipofuscin (HP:0011813) | 1.90450420 |
| 85 | Pulmonary infiltrates (HP:0002113) | 1.90244710 |
| 86 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86394538 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 1.86394538 |
| 88 | Abnormality of the peritoneum (HP:0002585) | 1.85988837 |
| 89 | Vacuolated lymphocytes (HP:0001922) | 1.85132605 |
| 90 | Interstitial pulmonary disease (HP:0006530) | 1.84818662 |
| 91 | Reticulocytosis (HP:0001923) | 1.83791415 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 1.82284336 |
| 93 | Joint stiffness (HP:0001387) | 1.81502139 |
| 94 | Verrucae (HP:0200043) | 1.80904598 |
| 95 | Papilloma (HP:0012740) | 1.80904598 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 1.79610741 |
| 97 | Cholecystitis (HP:0001082) | 1.79610741 |
| 98 | Hepatitis (HP:0012115) | 1.79331998 |
| 99 | Emphysema (HP:0002097) | 1.79015196 |
| 100 | Urticaria (HP:0001025) | 1.77691348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.88118322 |
| 2 | MAP4K1 | 3.43409795 |
| 3 | FGFR4 | 2.86656959 |
| 4 | MAP3K14 | 2.76103865 |
| 5 | TYK2 | 2.71559699 |
| 6 | PRPF4B | 2.47444761 |
| 7 | MAP3K13 | 2.40825652 |
| 8 | TRIB3 | 2.40771428 |
| 9 | GRK6 | 2.26720845 |
| 10 | RIPK4 | 2.10244143 |
| 11 | TESK2 | 2.10238530 |
| 12 | IRAK4 | 2.04885007 |
| 13 | MAP2K3 | 1.98157546 |
| 14 | TBK1 | 1.85026763 |
| 15 | SMG1 | 1.82912419 |
| 16 | CDK12 | 1.80872510 |
| 17 | TXK | 1.80037127 |
| 18 | SIK2 | 1.79871361 |
| 19 | SIK3 | 1.77985325 |
| 20 | SIK1 | 1.74616787 |
| 21 | EPHB1 | 1.68894319 |
| 22 | ZAP70 | 1.62963302 |
| 23 | MAP3K11 | 1.58625026 |
| 24 | JAK3 | 1.53379310 |
| 25 | JAK1 | 1.53110293 |
| 26 | BTK | 1.49939108 |
| 27 | BLK | 1.46147526 |
| 28 | FGFR3 | 1.42369310 |
| 29 | CSF1R | 1.35085264 |
| 30 | MAP3K10 | 1.33995143 |
| 31 | MAP2K2 | 1.32246998 |
| 32 | BCKDK | 1.28257730 |
| 33 | IKBKE | 1.27730430 |
| 34 | SYK | 1.19197314 |
| 35 | KDR | 1.16946442 |
| 36 | CDK4 | 1.16898191 |
| 37 | CSK | 1.16450910 |
| 38 | ITK | 1.15783745 |
| 39 | IKBKB | 1.13622860 |
| 40 | FES | 1.11463566 |
| 41 | IRAK3 | 1.11001538 |
| 42 | PRKD2 | 1.07708321 |
| 43 | TNK2 | 1.07337201 |
| 44 | EPHA3 | 1.00602581 |
| 45 | ICK | 0.99974786 |
| 46 | PKN2 | 0.96305856 |
| 47 | HCK | 0.96298260 |
| 48 | LCK | 0.96111913 |
| 49 | IRAK1 | 0.96017256 |
| 50 | KIT | 0.94901346 |
| 51 | MAPK11 | 0.92624948 |
| 52 | LYN | 0.91963758 |
| 53 | FGR | 0.91794415 |
| 54 | MAP3K7 | 0.87000265 |
| 55 | MARK3 | 0.86030962 |
| 56 | RPS6KA4 | 0.81876697 |
| 57 | STK10 | 0.80289061 |
| 58 | VRK2 | 0.79852700 |
| 59 | TEC | 0.79793647 |
| 60 | TAOK2 | 0.78424219 |
| 61 | LRRK2 | 0.78288777 |
| 62 | NLK | 0.78241036 |
| 63 | CDC42BPA | 0.77992586 |
| 64 | MARK2 | 0.74314853 |
| 65 | PTK6 | 0.72801480 |
| 66 | MAP3K1 | 0.72730972 |
| 67 | NME2 | 0.70162175 |
| 68 | MAPKAPK2 | 0.67672455 |
| 69 | NEK9 | 0.66823747 |
| 70 | CDK7 | 0.62739588 |
| 71 | MAP3K3 | 0.61322859 |
| 72 | MAPK7 | 0.61090775 |
| 73 | CDK9 | 0.60836901 |
| 74 | DYRK1B | 0.59576894 |
| 75 | MELK | 0.58088902 |
| 76 | JAK2 | 0.57461568 |
| 77 | BMX | 0.57282381 |
| 78 | PIM2 | 0.56088316 |
| 79 | MAPKAPK3 | 0.53994636 |
| 80 | EEF2K | 0.52473104 |
| 81 | RPS6KL1 | 0.51608262 |
| 82 | RPS6KC1 | 0.51608262 |
| 83 | CDK6 | 0.51342718 |
| 84 | TAOK3 | 0.50375364 |
| 85 | PRKG2 | 0.50003233 |
| 86 | PDPK1 | 0.49984396 |
| 87 | MATK | 0.48347454 |
| 88 | PRKCQ | 0.48137798 |
| 89 | TAOK1 | 0.47525398 |
| 90 | CHUK | 0.47012618 |
| 91 | DDR2 | 0.46106125 |
| 92 | NEK2 | 0.45934100 |
| 93 | IRAK2 | 0.44114704 |
| 94 | PIM1 | 0.42850126 |
| 95 | ATR | 0.41426942 |
| 96 | PAK4 | 0.40505503 |
| 97 | SCYL2 | 0.40218147 |
| 98 | PDGFRA | 0.39421014 |
| 99 | RET | 0.37348568 |
| 100 | TESK1 | 0.37170379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.58939138 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.05556069 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.50314551 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.45931965 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.22078072 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.15395777 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95086191 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90833920 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.88940922 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85777957 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.80060726 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.78246380 |
| 13 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75896243 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.71078444 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.70460178 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63788993 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.58067487 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55745382 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.53929593 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.49127129 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.42754165 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.38292447 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36878489 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36379964 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36260496 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35114487 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.34401878 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.29701041 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22706572 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21059508 |
| 31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19974252 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19375161 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.16720583 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16034415 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.11000298 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10133266 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.09626927 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09348114 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.06413374 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.05270698 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04282936 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04215496 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.03052684 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.02608974 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.01268129 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97537967 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95593235 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93738252 |
| 49 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93580874 |
| 50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.92444578 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.92204942 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.91628668 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90679618 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88269929 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87579268 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86119961 |
| 57 | Spliceosome_Homo sapiens_hsa03040 | 0.85276382 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.84993316 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.84675576 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.82786933 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80896437 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80673701 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77662748 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76212149 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76059937 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74205189 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71815308 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71572714 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70900796 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70877811 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66477274 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.66386808 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65712944 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65424950 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64484954 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59078479 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57822470 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56885666 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56108758 |
| 80 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55889383 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55395496 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54703387 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54203192 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52406385 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51957998 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51840606 |
| 87 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51766326 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.50906167 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48968603 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.47575662 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47214426 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 0.44179205 |
| 93 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.43979117 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43346136 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.42453385 |
| 96 | Legionellosis_Homo sapiens_hsa05134 | 0.41399624 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39646180 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36735199 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.34629362 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33250826 |

